Oral low-dose naltrexone in the treatment of grontal fibrosing alopecia and lichen planopilaris: An uncontrolled open-label prospective study

Authors

Remi K. Hamel, Washington University School of Medicine in St. Louis
Ling Chen, Washington University School of Medicine in St. Louis
Cailin O'Connell, Texas A&M University System Health Science Center
Caroline Mann, Washington University School of Medicine in St. Louis

Journal

Cureus

Publication Date

1-1-2023

Volume

15

Issue

1

First Page

e34169

Document Type

Open Access Publication

DOI

10.7759/cureus.34169

Rights and Permissions

Hamel RK, Chen L, O'Connell C, Mann C. Oral Low-Dose Naltrexone in the Treatment of Frontal Fibrosing Alopecia and Lichen Planopilaris: An Uncontrolled Open-Label Prospective Study. Cureus. 2023 Jan 24;15(1):e34169. doi: 10.7759/cureus.34169. © Copyright 2023 Hamel et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Recommended Citation

Hamel, Remi K.; Chen, Ling; O'Connell, Cailin; and Mann, Caroline, "Oral low-dose naltrexone in the treatment of grontal fibrosing alopecia and lichen planopilaris: An uncontrolled open-label prospective study." Cureus. 15, 1. e34169 (2023).
https://digitalcommons.wustl.edu/oa_4/1304

Department

ICTS (Institute of Clinical and Translational Sciences)